Novo Nordisk waves goodbye to VP in charge of device development
Kenneth Strømdahl has left Novo Nordisk after 17 year with the company. The past few years, he was responsible for the pharmaceutical company's Devices and Delivery Solutions division, where he oversaw more than 300 employees and the development of devices helping patients handle their diseases.
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY DANIEL PEDERSEN
After 17 years in several positions at Novo Nordisk, Kenneth Strømdahl is off to pastures new.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.